Cell therapy in patients with critical limb ischemia

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Compagna, Rita ^a,b   Amato, Bruno ^a,b   Massa, Salvatore ^b   Amato, Maurizio ^b   Grande, Raffaele ^a   Butrico, Lucia ^a   De Franciscis, Stefano ^a   Serra, Raffaele ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL FUNCTION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); CONGESTIVE HEART FAILURE; CRITICAL LIMB ISCHEMIA; CYTOLOGY; ENDOVASCULAR SURGERY; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INJECTION; INTRAARTERIAL STEM CELL INJECTION; INTRAMUSCULAR STEM CELL INJECTION; LEG REVASCULARIZATION; LIMB AMPUTATION; NONHUMAN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PERITONITIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEPSIS; STEM CELL; STEM CELL MOBILIZATION; STEM CELL TRANSPLANTATION; TREATMENT INDICATION; VASCULAR STEM CELL;

EID: 84938852764     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/931420     Document Type: Review

References (156)

1. S. Novo, G. Coppola, and G. Milio, "Critical limb ischemia: definition and natural history", Current Drug Targets-Cardiovascular and Haematological Disorders, vol. 4, no. 3, pp. 219-225, 2004.
2. L. Norgren, W. R. Hiatt, K. Bell et al., "Inter-society consensus for the management of peripheral arterial disease (TASC II)", European Journal of Vascular and Endovascular Surgery, vol. 33, no. 1, pp. S1-S75, 2007.
3. J. P. Simons, P. P. Goodney, B. W. Nolan, J. L. Cronenwett, L. M. Messina, and A. Schanzer, "Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia", Journal of Vascular Surgery, vol. 51, no. 6, pp. 1419-1424, 2010.
4. P. Libby, "Inflammation in atherosclerosis", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2045-2051, 2012.
5. H. Hioki, Y. Miyashita, T. Miura et al., "Prognostic improvement by multidisciplinary therapy in patients with critical limb ischemia", Angiology, 2014.
6. A. J. Henry, N. D. Hevelone, M. Belkin, and L. L. Nguyen, "Socioeconomic and hospital-related predictors of amputation for critical limb ischemia", Journal of Vascular Surgery, vol. 53, no. 2, pp. 330.e1-339.e1, 2011.
7. S. Matoba, T. Tatsumi, T. Murohara et al., "Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia", The American Heart Journal, vol. 156, no. 5, pp. 1010-1018, 2008.
8. B. Amann, C. Luedemann, R. Ratei, and J. A. Schmidt-Lucke, "Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease", Cell Transplantation, vol. 18, no. 3, pp. 371-380, 2009.
9. S. Rafii and D. Lyden, "Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration", Nature Medicine, vol. 9, no. 6, pp. 702-712, 2003.
10. N. Goldenberg-Cohen, B.-C. R. Avraham-Lubin, T. Sadikov, and N. Askenasy, "Effect of coadministration of neuronal growth factors on neuroglial differentiation of bone marrowderived stemcells in the ischemic retina", Investigative Ophthalmology & Visual Science, vol. 55, no. 1, pp. 502-512, 2013.
11. B. E. Strauer, M. Brehm, T. Zeus et al., "Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans", Circulation, vol. 106, no. 15, pp. 1913-1918, 2002.
12. B. Amato, R. Compagna, G. A. della Corte et al., "Peripheral blood mono-nuclear cells implantation in patients with peripheral arterial disease: a pilot study for clinical and biochemical outcome of neoangiogenesis", BMC Surgery, vol. 12, supplement 1, article S1, 2012.
13. R. W. Franz, A. Parks, K. J. Shah, T. Hankins, J. F. Hartman, and M. L. Wright, "Use of autologous bone marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease", Journal of Vascular Surgery, vol. 50, no. 6, pp. 1378-1390, 2009.
14. R. W. Franz, K. J. Shah, J. D. Johnson et al., "Short- to midterm results using autologous bone-marrow mononuclear cell implantation therapy as a limb salvage procedure in patients with severe peripheral arterial disease", Vascular and Endovascular Surgery, vol. 45, no. 5, pp. 398-406, 2011.
15. S. Rafii, S. Meeus, S. Dias et al., "Contribution of marrowderived progenitors to vascular and cardiac regeneration", Seminars in Cell and Developmental Biology, vol. 13, no. 1, pp. 61-67, 2002.
16. S. Rafii, B. Heissig, and K. Hattori, "Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors", Gene Therapy, vol. 9, no. 10, pp. 631-641, 2002.
17. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., "Embryonic stem cell lines derived from human blastocysts", Science, vol. 282, no. 5391, pp. 1145-1147, 1998.
18. E. Kiskinis and K. Eggan, "Progress toward the clinical application of patient-specific pluripotent stem cells", The Journal of Clinical Investigation, vol. 120, no. 1, pp. 51-59, 2010.
19. K. C. Rustad, V. W. Wong, M. Sorkin et al., "Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold", Biomaterials, vol. 33, no. 1, pp. 80-90, 2012.
20. G. Vogel, ""Stemness" genes still elusive", Science, vol. 302, no. 5644, article 371, 2003.
21. A. V. Evsikov and D. Solter, "Comment on ""Stemness": transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature"", Science, vol. 302, no. 5644, pp. 393-393, 2003.
22. A. Gerrits, B. Dykstra, M. Otten, L. Bystrykh, and G. De Haan, "Combining transcriptional profiling and genetic linkage analysis to uncover gene networks operating in hematopoietic stem cells and their progeny", Immunogenetics, vol. 60, no. 8, pp. 411-422, 2008.
23. B. Bhattacharya, S. Puri, and R. K. Puri, "A review of gene expression profiling of human embryonic stem cell lines and their differentiated progeny", Current Stem Cell Research and Therapy, vol. 4, no. 2, pp. 98-106, 2009.
24. D. Zhu, X. Wan, H. Huang et al., "Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells", Oncology Reports, vol. 31, no. 2, pp. 727-736, 2014.
25. M. de Felici, D. Farini, and S. Dolci, "In or out stemness: comparing growth factor signalling in mouse embryonic stem cells and primordial germcells", Current Stem Cell Research and Therapy, vol. 4, no. 2, pp. 87-97, 2009.
26. S. Topouzis and M. W. Majesky, "Smooth muscle lineage diversity in the chick embryo. Two types of aortic smooth muscle cell differ in growth and receptor-mediated transcriptional responses to transforming growth factor-β", Developmental Biology, vol. 178, no. 2, pp. 430-445, 1996.
27. B. Descamps and C. Emanueli, "Vascular differentiation from embryonic stem cells: novel technologies and therapeutic promises", Vascular Pharmacology, vol. 56, no. 5-6, pp. 267-279, 2012.
28. V. Barresi, A. Ieni, G. Branca, and G. Tuccari, "Brachyury: a diagnostic marker for the differential diagnosis of chordoma and hemangioblastoma versus neoplastic histological mimickers", Disease Markers, vol. 2014, Article ID514753, 7 pages, 2014.
29. S. Aramaki, K. Hayashi, K. Kurimoto et al., "A mesodermal factor, T, specifies mouse germ cell fate by directly activating germline determinants", Developmental Cell, vol. 27, no. 5, pp. 516-529, 2013.
30. A. W. Leung, D. Kent Morest, and J. Y. H. Li, "Differential BMP signaling controls formation and differentiation of multipotent preplacodal ectoderm progenitors from human embryonic stem cells", Developmental Biology, vol. 379, no. 2, pp. 208-220, 2013.
31. K. Kurpinski, H. Lam, J. Chu et al., "Transforming growth factor-β and notch signaling mediate stem cell differentiation into smoothmuscle cells", Stem Cells, vol. 28, no. 4, pp. 734-742, 2010.
32. A. D. Wolfe and K. M. Downs, "Mixl1 localizes to putative axial stem cell reservoirs and their posterior descendants in the mouse embryo", Gene Expression Patterns, vol. 15, no. 1, pp. 8-20, 2014.
33. R. P. Davis, E. S. Ng, M. Costa et al., "Targeting a GFP reporter gene to the MIXL1 locus of human embryonic stem cells identifies human primitive streak-like cells and enables isolation of primitive hematopoietic precursors", Blood, vol. 111, no. 4, pp. 1876-1884, 2008.
34. C. Fuerer, M. C. Nostro, and D. B. Constam, "Nodal·Gdf1 heterodimers with bound prodomains enable serum-independent nodal signaling and endoderm differentiation", The Journal of Biological Chemistry, vol. 289, no. 25, pp. 17854-17871, 2014.
35. V. Hall and P. Hyttel, "Breaking down pluripotency in the porcine embryo reveals both a premature and reticent stem cell state in the inner cell mass and unique expression profiles of the naïve and primed stem cell states", Stem Cells and Development, vol. 23, no. 17, pp. 2030-2045, 2014.
36. V. Hall and P. Hyttel, "Breaking down pluripotency in the porcine embryo reveals both a premature and reticent stem cell state in the inner cell mass and unique expression profiles of the naïve and primed stem cell states", Stem Cells and Development, vol. 23, no. 17, pp. 2030-2045, 2014.
37. P. Reményi, L. Gopcsa, I. Marton et al., "Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF", Advances in Therapy, vol. 31, no. 4, pp. 451-460, 2014.
38. M. N. Shalaby, M. Saad, S. Akar, M. A. Reda, and A. Shalgham, "The role of aerobic and anaerobic training programs on CD (34+) stemcells and chosen physiological variables", Journal of Human Kinetics, vol. 35, no. 1, pp. 69-79, 2012.
39. M. Saravanakumar and H. Devaraj, "Distribution and homing pattern of c-kit+ Sca-1+ CXCR4+ resident cardiac stem cells in neonatal, postnatal, and adult mouse heart", Cardiovascular Pathology, vol. 22, no. 4, pp. 257-263, 2013.
40. D. D. Houlihan, Y. Mabuchi, S. Morikawa et al., "Isolation of mouse mesenchymal stem cells on the basis of expression of Sca-1 and PDGFR-..", Nature Protocols, vol. 7, no. 12, pp. 2103-2111, 2012.
41. H. Ishimine, N. Yamakawa, M. Sasao et al., "N-Cadherin is a prospective cell surface marker of human mesenchymal stem cells that have high ability for cardiomyocyte differentiation", Biochemical and Biophysical Research Communications, vol. 438, no. 4, pp. 753-759, 2013.
42. K. Zhang, K. Pang, and X. Wu, "Isolation and transplantation of corneal endothelial cell-like cells derived from in-vitrodifferentiated human embryonic stem cells", Stem Cells and Development, vol. 23, no. 12, pp. 1340-1354, 2014.
43. Y. Li, W. X. Hong, B. Lan et al., "PDGF mediates derivation of human embryonic germ cells", Differentiation, vol. 86, no. 4-5, pp. 141-148, 2014.
44. S. Valente, F. Alviano, C. Ciavarella et al., "Human cadaver multipotent stromal/stem cells isolated from arteries stored in liquid nitrogen for 5 years", Stem Cell Research and Therapy, vol. 5, no. 1, article 8, 2014.
45. X. Yao, Y. Ping, Y. Liu et al., "Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells", PLoS ONE, vol. 8, no. 3, Article ID e57188, 2013.
46. M. Sano and K. Fukuda, "The selective VEGFR inhibitor PTK787/ZK 222584 represses the activities of VEGFR-negative bone marrow-derived mesenchymal stem cells", Cancer Biology and Therapy, vol. 8, no. 13, pp. 1249-1251, 2009.
47. M. Voskuil, N. van Royen, I. Hoefer, I. Buschmann, W. Schaper, and J. J. Piek, "Angiogenesis and arteriogenesis: the long journey fromconcept to clinical application", Nederlands Tijdschrift voor Geneeskunde, vol. 145, no. 14, pp. 670-675, 2001.
48. N. van Royen, J. J. Piek, I. Buschmann, I. Hoefer, M. Voskuil, and W. Schaper, "Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease", Cardiovascular Research, vol. 49, no. 3, pp. 543-553, 2001.
49. Z. Raval and D. W. Losordo, "Cell therapy of peripheral arterial disease: from experimental findings to clinical trials", Circulation Research, vol. 112, no. 9, pp. 1288-1302, 2013.
50. H. Lawall, P. Bramlage, and B. Amann, "Treatmentofperipheral arterial disease using stem and progenitor cell therapy", Journal of Vascular Surgery, vol. 53, no. 2, pp. 445-453, 2011.
51. I. Eitenmüller, O. Volger, A. Kluge et al., "The range of adaptation by collateral vessels after femoral artery occlusion", Circulation Research, vol. 99, no. 6, pp. 656-662, 2006.
52. M. Heil and W. Schaper, "Influence of mechanical, cellular, and molecular factors on collateral artery growth (Arteriogenesis)", Circulation Research, vol. 95, no. 5, pp. 449-458, 2004.
53. B. Park, A. Hoffman, Y. Yang et al., "Endothelial nitric oxide synthase affects both early and late collateral arterial adaptation and blood flow recovery after induction of hind limb ischemia in mice", Journal of Vascular Surgery, vol. 51, no. 1, pp. 165-173, 2010.
54. Y. Xu, H. Meng, C. Li et al., "Umbilical cord-derived mesenchymal stem cells isolated by a novel explantation technique can differentiate into functional endothelial cells and promote revascularization", Stem Cells and Development, vol. 19, no. 10, pp. 1511-1522, 2010.
55. W. Kim, H. J. Myung, H. C. Suk et al., "Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers", Circulation Journal, vol. 70, no. 8, pp. 1052-1057, 2006.
56. J. F. Gómez-Cerezo, B. Pagán-Muñoz, M. López-Rodríguez, M. Estébanez-Muñoz, and F. J. Barbado-Hernández, "The role of endothelial progenitor cells and statins in endothelial function: a review", Cardiovascular & Hematological Agents in Medicinal Chemistry, vol. 5, no. 4, pp. 265-272, 2007.
57. V. Adams, A. Linke, F. Breuckmann et al., "Circulating progenitor cells decrease immediately after marathon race in advancedage marathon runners", European Journal of Cardiovascular Prevention and Rehabilitation, vol. 15, no. 5, pp. 602-607, 2008.
58. R. Serra, G. Buffone, G. Costanzo et al., "Altered metalloproteinase-9 expression as least common denominator between varicocele, inguinal hernia, and chronic venous disorders", Annals of Vascular Surgery, vol. 28, no. 3, pp. 705-709, 2014.
59. B. Amato, G. Coretti, R. Compagna et al., "Role of matrix metalloproteinases in non-healing venous ulcers", International Wound Journal, 2013.
60. R. Serra, G. Buffone, D. Falcone et al., "Chronic venous leg ulcers are associated with high levels of metalloproteinases-9 and neutrophil gelatinase-associated lipocalin", Wound Repair and Regeneration, vol. 21, no. 3, pp. 395-401, 2013.
61. R. Serra, R. Grande, G. Buffone, L. Gallelli, and S. de Franciscis, "The effects of minocycline on extracellular matrix in patients with chronic venous leg ulcers", Acta Phlebologica, vol. 14, no. 3, pp. 99-107, 2013.
62. R. Serra, R. Grande, L. Butrico et al., "Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration", International Wound Journal, 2014.
63. R. Serra, L. Gallelli, G. Buffone et al., "Doxycycline speeds up healing of chronic venous ulcers", International Wound Journal, 2013.
64. R. Serra, L. Gallelli, A. Conti et al., "The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs", Drug Design, Development and Therapy, vol. 8, pp. 519-527, 2014.
65. R. Serra, R. Grande, G. Buffone et al., "Extracellular matrix assessment of infected chronic venous leg ulcers: role of metalloproteinases and inflammatory cytokines", International Wound Journal, 2014.
66. M. T. Busceti, R. Grande, B. Amato et al., "Pulmonary embolism, metalloproteinases and neutrophil gelatinase associated lipocalin", Acta Phlebologica, vol. 14, no. 3, pp. 115-121, 2013.
67. S. de Franciscis, P. Mastroroberto, L. Gallelli, G. Buffone, R. Montemurro, and R. Serra, "Increased plasma levels of metalloproteinase-9 and neutrophil gelatinaseeassociated lipocalin in a rare case of multiple artery aneurysm", Annals of Vascular Surgery, vol. 27, no. 8, pp. 1185.e5-1185.e7, 2013.
68. S. de Franciscis, L. Gallelli, L. Battaglia et al., "Cilostazol prevents foot ulcers in diabetic patientswith peripheral vascular disease", International Wound Journal, 2013.
69. R. Serra, R. Grande, L. Gallelli et al., "Carotid body paragangliomas and Matrix metalloproteinases", Annals of Vascular Surgery, 2014.
70. S. de Franciscis, R. Grande, L. Butrico et al., "Resection of Carotid Body Tumors reduces arterial blood pressure. An underestimated neuroendocrine syndrome", International Journal of Surgery, vol. 12, supplement 2, pp. S63-S67, 2014.
71. R. Serra, R. Grande, G. Buffone et al., "Effects of glucocorticoids and tumor necrosis factor-alpha inhibitors on both clinical and molecular parameters in patients with Takayasu arteritis", Journal of Pharmacology & Pharmacotherapeutics, vol. 5, no. 3, pp. 193-196, 2014.
72. R. Serra, G. Volpentesta, L. Gallelli et al., "Metalloproteinase-9 and neutrophil gelatinase-associated lipocalin plasma and tissue levels evaluation in middle cerebral artery aneurysms", British Journal of Neurosurgery, 2014.
73. C. Lombard, J. Saulnier, and J. Wallach, "Assays of matrix metalloproteinases (MMPs) activities: a review", Biochimie, vol. 87, no. 3-4, pp. 265-272, 2005.
74. S. Siddiq, D. Pamphilon, S. Brunskill, C. Doree, C. Hyde, and S. Stanworth, "Bone marrow harvest versus peripheral stem cell collection for haemopoietic stem cell donation in healthy donors", Cochrane Database of Systematic Reviews, no. 1, Article ID CD006406, 2009.
75. Y. Vagima, A. Avigdor, P. Goichberg et al., "MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization", Journal of Clinical Investigation, vol. 119, no. 3, pp. 492-503, 2009.
76. T. Takahashi, C. Kalka, H. Masuda et al., "Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization", Nature Medicine, vol. 5, no. 4, pp. 434-438, 1999.
77. R. Haas and S. Murea, "The role of granulocyte colonystimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells", Cytokines and Molecular Therapy, vol. 1, no. 4, pp. 249-270, 1995.
78. K. Hölig, M. Kramer, F. Kroschinsky et al., "Safety and efficacy of hematopoietic stemcell collection frommobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors", Blood, vol. 114, no. 18, pp. 3757-3763, 2009.
79. A. Dar, O. Kollet, and T. Lapidot, "Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice", Experimental Hematology, vol. 34, no. 8, pp. 967-975, 2006.
80. D. C. Link, "Mechanisms of granulocyte colony-stimulating factor induced hematopoietic progenitor-cell mobilization", Seminars in Hematology, vol. 37, no. 1, supplement 2, pp. 25-32, 2000.
81. S. M. Devine, N. Flomenberg, D. H. Vesole et al., "Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma", Journal of Clinical Oncology, vol. 22, no. 6, pp. 1095-1102, 2004.
82. I. Pusic and J. F. Dipersio, "Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells", Current Opinion in Hematology, vol. 17, no. 4, pp. 319-326, 2010.
83. J. Poole, K. Mavromatis, J. N. Binongo et al., "Effect of progenitor cellmobilization with granulocyte-macrophage colonystimulating factor in patients with peripheral artery disease: a randomized clinical trial", The Journal of the American Medical Association, vol. 310, no. 24, pp. 2631-2639, 2013.
84. K. Ballen, "Targeting the stem cell niche: squeezing blood from bones", Bone Marrow Transplantation, vol. 39, no. 11, pp. 655-660, 2007.
85. N. Rashidi and G. B. Adams, "The influence of parathyroid hormone on the adult hematopoietic stem cell niche", Current Osteoporosis Reports, vol. 7, no. 2, pp. 53-57, 2009.
86. Y. Porat, E. Assa-Kunik, M. Belkin et al., "A novel potential therapy for vascular diseases: blood-derived stem/progenitor cells specifically activated by dendritic cells", Diabetes/Metabolism Research and Reviews, vol. 30, no. 7, pp. 623-634, 2014.
87. E. Gussoni, Y. Soneoka, C. D. Strickland et al., "Dystrophin expression in the mdx mouse restored by stem cell transplantation", Nature, vol. 401, no. 6751, pp. 390-394, 1999.
88. C. A. Hart, J. Tsui, A. Khanna, D. J. Abraham, and D. M. Baker, "Stem cells of the lower limb: their role and potential in management of critical limb ischemia", Experimental Biology and Medicine, vol. 238, no. 10, pp. 1118-1126, 2013.
89. L. Kassar-Duchossoy, B. Gayraud-Morel, D. Gomès et al., "Mrf4 determines skeletal muscle identity in Myf5: Myod doublemutant mice", Nature, vol. 431, no. 7007, pp. 466-471, 2004.
90. T. P. White and K. A. Esser, "Satellite cell and growth factor involvement in skeletal muscle growth", Medicine and Science in Sports and Exercise, vol. 21, no. 5, pp. S158-S163, 1989.
91. J. Kawiak, E. Brzóska, I. Grabowska et al., "Contribution of stem cells to skeletal muscle regeneration", Folia Histochemica et Cytobiologica, vol. 44, no. 2, pp. 75-79, 2006.
92. S. E. Epstein, S. Fuchs, Y. F. Zhou, R. Baffour, and R. Kornowski, "Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards", Cardiovascular Research, vol. 49, no. 3, pp. 532-542, 2001.
93. T. Kinnaird, E. Stabile, M. S. Burnett, and S. E. Epstein, "Bone marrow-derived cells for enhancing collateral development: mechanisms, animal data, and initial clinical experiences", Circulation Research, vol. 95, no. 4, pp. 354-363, 2004.
94. A. Bura, V. Planat-Benard, P. Bourin et al., "Phase I trial: the use of autologous cultured adipose-derived stroma/stemcells to treat patients with non-revascularizable critical limb ischemia", Cytotherapy, vol. 16, no. 2, pp. 245-257, 2014.
95. K. Zhi, Z. Gao, J. Bai et al., "Application of adipose-derived stem cells in critical limb ischemia", Frontiers in Bioscience, vol. 19, pp. 768-776, 2014.
96. W. R. Prather, A. Toren, M. Meiron, R. Ofir, C. Tschope, and E. Horwitz, "The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemi", Cytotherapy, vol. 11, no. 4, pp. 427-434, 2009.
97. G. Bilic, S. M. Zeisberger, A. S. Mallik, R. Zimmermann, and A. H. Zisch, "Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy", Cell Transplantation, vol. 17, no. 8, pp. 955-968, 2008.
98. G. Pratama, V. Vaghjiani, J. Y. Tee et al., "Changes in culture expanded human amniotic epithelial cells: implications for potential therapeutic applications", PLoS ONE, vol. 6, no. 11, Article ID e26136, 2011.
99. H. Suzuki and Y. Iso, "Clinical application of vascular regenerative therapy for peripheral artery disease", Bio Med Research International, vol. 2013, Article ID 179730, 6 pages, 2013.
100. G. Song, X. Li, Y. Shen et al., "Transplantation of iPSc restores cardiac function by promoting angiogenesis and ameliorating Cardiac remodeling in a post-infarcted swine model", Cell Biochemistry and Biophysics, 2014.
101. S. Sasaki, T. Inoguchi, K. Muta et al., "Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells", The American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 1, pp. H657-H665, 2007.
102. K.-I. Sasaki, C. Heeschen, A. Aicher et al., "Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy", Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 39, pp. 14537-14541, 2006.
103. T. Kinnaird, E. S. Burnett, M. Shou et al., "Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrinemechanisms", Circulation, vol. 109, no. 12, pp. 1543-1549, 2004.
104. K. Kondoh, H. Koyama, T. Miyata, T. Takato, H. Hamada, and H. Shigematsu, "Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor", Cardiovascular Research, vol. 61, no. 1, pp. 132-142, 2004.
105. D. Versari, L. O. Lerman, and A. Lerman, "The importance of reendothelialization after arterial injury", Current Pharmaceutical Design, vol. 13, no. 17, pp. 1811-1824, 2007.
106. Z. Boda, M. Udvardy, K. Farkas et al., "Autologous bone marrow-derived stem cell therapy in patients with severe peripheral arterial disorder", Orvosi Hetilap, vol. 149, no. 12, pp. 531-540, 2008.
107. R. B. van Tongeren, J. F. Hamming, W. E. Fibbe et al., "Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia", Journal of Cardiovascular Surgery, vol. 49, no. 1, pp. 51-58, 2008.
108. R. Lara-Hernandez, P. Lozano-Vilardell, P. Blanes, N. Torreguitart-Mirada, A. Galmés, and J. Besalduch, "Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia", Annals of Vascular Surgery, vol. 24, no. 2, pp. 287-294, 2010.
109. Z. Dong, B. Chen, W. Fu et al., "Transplantation of purified CD34+ cells in the treatment of critical limb ischemia", Journal of Vascular Surgery, vol. 58, no. 2, pp. 404.e3-411.e3, 2013.
110. V. Subramaniyam, E. K. Waller, J. R. Murrow et al., "Bone marrow mobilization with granulocyte macrophage colonystimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease", American Heart Journal, vol. 158, no. 1, pp. 53.e1-60.e1, 2009.
111. J. N. Winter, H. M. Lazarus, A. Rademaker et al., "Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for themobilization of hematopoietic progenitor cells", Journal of Clinical Oncology, vol. 14, no. 1, pp. 277-286, 1996.
112. K. Moazzami, R. Majdzadeh, and S. Nedjat, "Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia", The Cochrane Database of Systematic Reviews, no. 12, Article ID CD008347, 2011.
113. M. Shimamura, H. Nakagami, H. Koriyama, and R. Morishita, "Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease", Bio Med Research International, vol. 2013, Article ID 186215, 8 pages, 2013.
114. R. A. Mangiafico and M. Mangiafico, "Medical treatment of critical limb ischemia: current state and future directions", Current Vascular Pharmacology, vol. 9, no. 6, pp. 658-676, 2011.
115. K. Tateno, T. Minamino, H. Toko et al., "Critical roles ofmusclesecreted angiogenic factors in therapeutic neovascularization", Circulation Research, vol. 98, no. 9, pp. 1194-1202, 2006.
116. G. P. Fadini, C. Agostini, and A. Avogaro, "Autologous stem cell therapy for peripheral arterial disease. Meta-analysis and systematic review of the literature", Atherosclerosis, vol. 209, no. 1, pp. 10-17, 2010.
117. Y.-Q. Gu, J. Zhang, L.-R. Guo et al., "Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia", Chinese Medical Journal, vol. 121, no. 11, pp. 963-967, 2008.
118. E. Tateishi-Yuyama, H. Matsubara, T. Murohara et al., "Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial", The Lancet, vol. 360, no. 9331, pp. 427-435, 2002.
119. Z. Boda, Z. Veréb, and É. Rajnavolgji, "Autologous bonemarrow stem cell or peripheral blood endothelial progenitor cell therapy in patients with peripheral limb ischaemia", Orvosi Hetilap, vol. 147, no. 25, pp. 1155-1160, 2006.
120. A. T. Hirsch, "Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting", Circulation, vol. 114, no. 24, pp. 2581-2583, 2006.
121. J. Moriya, T. Minamino, K. Tateno et al., "Long-term outcome of therapeutic neovascularization using peripheral blood mononuclear cells for limb ischemia", Circulation: Cardiovascular Interventions, vol. 2, no. 3, pp. 245-254, 2009.
122. D. W. Losordo, M. R. Kibbe, F. Mendelsohn et al., "A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia", Circulation: Cardiovascular Interventions, vol. 5, no. 6, pp. 821-830, 2012.
123. S. Sugihara, Y. Yamamoto, T. Matsuura et al., "Age-related BMMNC dysfunction hampers neovascularization", Mechanisms of Ageing and Development, vol. 128, no. 9, pp. 511-516, 2007.
124. R. J. Powell, A. J. Comerota, S. A. Berceli et al., "Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia", Journal of Vascular Surgery, vol. 54, no. 4, pp. 1032-1041, 2011.
125. R. J. Powell, "Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia", Journal of Vascular Surgery, vol. 56, no. 1, pp. 264-266, 2012.
126. T. B. Jonsson, T. Larzon, B. Arfvidsson et al., "Adverse events during treatment of critical limb ischemia with autologous peripheral bloodmononuclear cell implant", International Angiology, vol. 31, no. 1, pp. 77-84, 2012.
127. C. A. Vlahu, B. A. Lemkes, D. G. Struijk, M. G. Koopman, R. T. Krediet, and H. Vink, "Damage of the endothelial glycocalyx in dialysis patients", Journal of the American Society of Nephrology, vol. 23, no. 11, pp. 1900-1908, 2012.
128. L. Shin and D. A. Peterson, "Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes", Stem Cells Translational Medicine, vol. 1, no. 2, pp. 125-135, 2012.
129. R. Kishore, S. K. Verma, A. R. Mackie et al., "Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155modulates fibrotic response in diabetic hearts", PLoS ONE, vol. 8, no. 4, Article ID e60161, 2013.
130. J. Honold, R. Lehmann, C. Heeschen et al., "Effects of granulocyte colony simulating factor on functional activities of endothelial progenitor cells in patients with chronic ischemic heart disease", Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 10, pp. 2238-2243, 2006.
131. M. R. Finney, N. J. Greco, S. E. Haynesworth et al., "Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia", Biology of Blood and Marrow Transplantation, vol. 12, no. 5, pp. 585-593, 2006.
132. Y.-F. Liao, Y. Feng, L.-L. Chen, T.-S. Zeng, F. Yu, and L.-J. Hu, "Coronary heart disease risk equivalence in diabetes and arterial diseases characterized by endothelial function and endothelial progenitor cell", Journal of Diabetes and Its Complications, vol. 28, no. 2, pp. 214-218, 2014.
133. D. P. Slovut and T. M. Sullivan, "Critical limb ischemia: medical and surgical management", Vascular Medicine, vol. 13, no. 3, pp. 281-291, 2008.
134. C. Altaner, V. Altanerova, M. Cihova et al., "Characterization of mesenchymal stem cells of "no-options" patients with critical limb ischemia treated by autologous bonemarrowmononuclear cells", PLoS ONE, vol. 8, no. 9, Article ID e73722, 2013.
135. R. Marfella, C. Luongo, A. Coppola et al., "Use of a nonspecific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients", Atherosclerosis, vol. 208, no. 2, pp. 473-479, 2010.
136. B. H. Strauss, "Diabetic patients receiving bare-metal stents: no option patients?" Journal of the American College of Cardiology, vol. 61, no. 16, pp. 1686-1687, 2013.
137. L. Norgren, W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes, "Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)", Journal of Vascular Surgery, vol. 45, supplement, no. 1, pp. S5-S67, 2007.
138. E. Benoit, T. F. O'Donnell Jr., G. D. Kitsios, and M. D. Iafrati, "Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement", Journal of Vascular Surgery, vol. 55, no. 3, pp. 781-789, 2012.
139. J. A. González-Fajardo, J. A. Brizuela-Sanz, B. Aguirre-Gervás et al., "Prognostic significance of an elevated neutrophillymphocyte ratio in the amputation-free survival of patients with chronic critical limb ischemia", Annals of Vascular Surgery, vol. 28, no. 4, pp. 999-1004, 2014.
140. E. Saarinen, N. Sugano, F. Biancari et al., "Therapeutic approach to CLI with tissue loss-a comparative prospective cohort study in Finland and Japan", Annals of Vascular Surgery, vol. 28, no. 6, pp. 1426-1431, 2014.
141. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., "Embryonic stem cell lines derived from human blastocysts", Science, vol. 282, no. 5391, pp. 1145-1147, 1998.
142. T. Asahara, T. Murohara, A. Sullivan et al., "Isolation of putative progenitor endothelial cells for angiogenesis", Science, vol. 275, no. 5302, pp. 964-967, 1997.
143. R. Nizankowski, T. Petriczek, A. Skotnicki, and A. Szczeklik, "The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation", Kardiologia Polska, vol. 63, no. 4, pp. 351-360, 2005.
144. C. Napoli, B. Farzati, V. Sica et al., "Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia", European Journal of Cardiovascular Prevention and Rehabilitation, vol. 15, no. 6, pp. 709-718, 2008.
145. V. Procházka, J. Gumulec, J. Chmelová et al., "Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot", Vnitrni Lekarstvi, vol. 55, no. 3, pp. 173-178, 2009.
146. S. Matoba, T. Tatsumi, T. Murohara et al., "TACT Follow-up Study Investigators. Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia", The American Heart Journal, vol. 156, no. 5, pp. 1010-1018, 2008.
147. A. Kawamura, T. Horie, I. Tsuda et al., "Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs", Journal of Artificial Organs, vol. 9, no. 4, pp. 226-233, 2006.
148. P. P. Huang, X. F. Yang, S. Z. Li, J. C. Wen, Y. Zhang, and Z. C. Han, "Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans", Thrombosis and Haemostasis, vol. 98, no. 6, pp. 1335-1342, 2007.
149. E. Tateishi-Yuyama, H. Matsubara, T. Murohara et al., "Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial", The Lancet, vol. 360, no. 9331, pp. 427-435, 2002.
150. V. Motukuru, K. R. Suresh, V. Vivekanand, S. Raj, and K. R. Girija, "Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells", Journal of Vascular Surgery, vol. 48, no. 6, pp. 53S-60S, 2008.
151. F. Benetti, E. Peñaherrera, T. Maldonado, Y. D. Vera, V. Subramanian, and L. Geffner, "Direct myocardial implantation of human fetal stem cells in heart failure patients: long-term results", Heart Surgery Forum, vol. 13, no. 1, pp. E31-E35, 2010.
152. R. K. Burt, A. Testori, Y. Oyama et al., "Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia", Bone Marrow Transplantation, vol. 45, no. 1, pp. 111-116, 2010.
153. G. O. Ouma, R. A. Jonas, M. H. U. Usman, and E. R. Mohler, "Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease", Vascular Medicine, vol. 17, no. 3, pp. 174-192, 2012.
154. G. P. Lasala, J. A. Silva, P. A. Gardner, and J. J. Minguell, "Combination stemcell therapy for the treatment of severe limb ischemia: safety and efficacy analysis", Angiology, vol. 61, no. 6, pp. 551-556, 2010.
155. N. R. Dash, S. N. Dash, P. Routray, S. Mohapatra, and P. C. Mohapatra, "Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells", Rejuvenation Research, vol. 12, no. 5, pp. 359-366, 2009.
156. J. Yan, G. Tie, T. Y. Xu, K. Cecchini, and L. M. Messina, "Mesenchymal stem cells as a treatment for peripheral arterial disease: current status and potential impact of type II diabetes on their therapeutic efficacy", Stem Cell Reviews and Reports, vol. 9, no. 3, pp. 360-372, 2013.